Company Company is dedicated to transforming scientific potential into meaningful innovations for underserved neurological and rare disease communities globally. Its commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome. The company is actively engaged in developing future therapeutic...